LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹10,511 Cr | ₹9,336 Cr | ₹8,387 Cr | ₹7,660 Cr | ₹6,968 Cr |
What is the latest Total Liabilities ratio of LAURUS LABS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹10,511 Cr |
| Mar2025 | ₹9,336 Cr |
| Mar2024 | ₹8,387 Cr |
| Mar2023 | ₹7,660 Cr |
| Mar2022 | ₹6,968 Cr |
How is Total Liabilities of LAURUS LABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹10,511 Cr | 12.59 | |
| Mar2025 | ₹9,336 Cr | 11.31 | |
| Mar2024 | ₹8,387 Cr | 9.49 | |
| Mar2023 | ₹7,660 Cr | 9.94 | |
| Mar2022 | ₹6,968 Cr | - | |
Compare Total Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹105,704.3 Cr | 1.1% | 7.8% | 113% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 1.1% |
7.8% |
113% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses